COLUCID PHARMACEUTICALS INC's ticker is CLCD and the CUSIP is 19716T101. A total of 21 filers reported holding COLUCID PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $26,000 | +4.0% | 722 | +11.6% | 0.00% | – |
| Q3 2016 | $25,000 | +400.0% | 647 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 647 | -18.3% | 0.00% | – |
| Q1 2016 | $5,000 | +400.0% | 792 | +446.2% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 145 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 145 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,056,563 | $11,829,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,250 | $1,228,000 | 0.16% |
| PIPER SANDLER & CO. | 5,215 | $20,000 | 0.02% |
| Pentwater Capital Management LP | 483,686 | $1,872,000 | 0.02% |
| MPM ASSET MANAGEMENT LLC | 21,806 | $84,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 100,794 | $390,000,000 | 0.01% |
| VANGUARD GROUP INC | 4,540,091 | $161,209,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,555 | $45,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,355,835 | $5,247,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 31,891 | $123,000 | 0.00% |